Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-025837
Filing Date
2021-06-24
Accepted
2021-06-24 21:13:37
Documents
2
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6494
2 EX-24 DOCUMENT attachment1.htm EX-24 4741
  Complete submission text file 0000899243-21-025837.txt   12764
Mailing Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080
Business Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Issuer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GRAPHITE BIO, INC. 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080
Business Address
Stultz Katherine V (Reporting) CIK: 0001864500 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40532 | Film No.: 211044418